octobre 1, 2012 Regulators of innate immunity as novel targets for panviral therapeutics. Es-Saad S, Tremblay N, Baril M, Lamarre DCurr Opin Virol 2012-10-01 ;2( 5 ):622-8
octobre 1, 2012 Direct-acting and host-targeting HCV inhibitors: current and future directions. Chatel-Chaix L, Germain MA, Götte M, Lamarre DCurr Opin Virol 2012-10-01 ;2( 5 ):588-98
octobre 1, 2012 Identification and Characterization of an Activating F229V Substitution in the V2 Vasopressin Receptor in an Infant with NSIAD. Carpentier E, Greenbaum LA, Rochdi D, Abrol R, Goddard WA, Bichet DG, Bouvier MJ. Am. Soc. Nephrol. 2012-10-01 ;23( 10 ):1635-40
octobre 1, 2012 RhoA activation during polarization and cytokinesis of the early Caenorhabditis elegans embryo is differentially dependent on NOP-1 and CYK-4. Tse YC, Werner M, Longhini KM, Labbé JC, Goldstein B, Glotzer MMol. Biol. Cell 2012-10-01 ;23( 20 ):4020-31
octobre 1, 2012 RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation. Saha M, Carriere A, Cheerathodi M, Zhang X, Lavoie G, Rush J, Roux PP, Ballif BABiochem. J. 2012-10-01 ;447( 1 ):159-66
octobre 1, 2012 Role of SUMOylation in full antiestrogenicity. Hilmi K, Hussein N, Mendoza-Sanchez R, El-Ezzy M, Ismail H, Durette C, Bail M, Rozendaal MJ, Bouvier M, Thibault P, Gleason JL, Mader SMol. Cell. Biol. 2012-10-01 ;32( 19 ):3823-37
octobre 1, 2012 Sample preparation and analytical strategies for large-scale phosphoproteomics experiments. Kanshin E, Michnick S, Thibault PSemin. Cell Dev. Biol. 2012-10-01 ;23( 8 ):843-53
septembre 28, 2012 Restructuring g-protein- coupled receptor activation. Audet M, Bouvier MCell 2012-09-28 ;151( 1 ):14-23